Nonetheless, AZD3965 reduced tumor growth in mice possibly due disruption of bioenergetics and the TCA cycle, as suggested by the reduction of TCA cycle intermediates paired with downregulation of PDH activity. This evidence concerns the gene PDP1 and neoplasm.